Sarissa is a private limited company. It has secured significant funding from a range of investors including venture capital funds, family offices, private investors, public institutions, founders and management.

Wren Capital have recently made a significant equity investment in Sarissa. https://www.wrencapital.co.uk/
The Wellcome Trust facilitated the formation of Sarissa by providing funding which enabled Prof Dale to create the technology which underpins Sarissa’s biosensors. https://wellcome.ac.uk/about-us
The University of Warwick. Sarissa is a Warwick University spin-out. The University acquired a shareholding in the company at the time of its formation and has subsequently made further investments in the company. https://www2.warwick.ac.uk/services/ventures/